New covid booster shots with an updated formula targeting XBB subvariants of the virus is expected to hit the market in late September, pending regulatory approvals by the Food and Drug Administration, guidance from the Centers for Disease Control and Prevention on who should get an updated shot, and timely delivery by manufacturers.